Int J Stomatol ›› 2020, Vol. 47 ›› Issue (1): 115-120.doi: 10.7518/gjkq.2020029

• Orginal Article • Previous Articles     Next Articles

Progress for understanding the effect of berberine in oral diseases

Cui Yujia,Sun Jianxun(),Zhou Xuedong   

  1. State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Operative Dentistry and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
  • Received:2019-05-07 Revised:2019-09-24 Online:2020-01-01 Published:2020-01-01
  • Contact: Jianxun Sun
  • Supported by:
    This study was supported by Sichuan Science and Technology Pillar Program(2016RZ0035)


Berberine is a benzylisoquinoline alkaloid, occurring as one of the main active ingredients in many traditional herbs including coptis, barberry, phellodendron. Several studies have depicted its anticonvulsant, antihypertensive, antidepressant, anti-inflammatory, hypolipidemic, and antidiabetic biological effect. Depending on a rich and varied biological function, the potential of berberine for curing oral diseases has been discovered recently. Researchers focus on the relation of berberine to oral diseases, such as periodontitis, caries, periapical periodontitis, diseases of oral mucosa, oral/maxillofacial. The review pays attention to the biological function of berberine as well as its roles in oral diseases.

Key words: berberine, caries, periapical periodontitis, periodontitis, diseases of oral mucosa, tumor

CLC Number: 

  • R78

[1] Birdsall TC, Kelly GS . Berberine: therapeutic po-tential of an alkaloid found in several medicinal plants[J]. Alt Med Rev, 1997,2(2):94-103.
[2] 曹鹏, 张紫薇, 李滢 , 等. 异喹啉类生物碱抑菌活性及抑菌机制研究进展[J]. 中国中药杂志, 2016,41(14):2600-2606.
Cao P, Zhang ZW, Li Y , et al. Progress of antibacterial activity and antibacterial mechanism of isoquinoline alkaloids[J]. China J Chin Mater Med, 2016,41(14):2600-2606.
[3] Gao WW, Gopala L, Bheemanaboina RRY , et al. Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter bau-manii[J]. Eur J Med Chem, 2018,146:15-37.
[4] Bang S, Kwon H, Hwang HS , et al. 9-O-butyl-13-(4-isopropylbenzyl) berberine, KR-72, is a potent an-tifungal agent that inhibits the growth of Cryptococcus neoformans by regulating gene expression[J]. PLoS One, 2014,9(10):e109863.
[5] Li H, Li XL, Zhang M , et al. Berberine ameliorates experimental autoimmune neuritis by suppressing both cellular and humoral immunity[J]. Scand J Im-munol, 2014,79(1):12-19.
[6] Wang X, He X, Zhang CF , et al. Anti-arthritic effect of berberine on adjuvant-induced rheumatoid arthri-tis in rats[J]. Biomed Pharmacother, 2017,89:887-893.
[7] Kawano M, Takagi R, Kaneko A , et al. Berberine is a dopamine D1- and D2-like receptor antagonist and ameliorates experimentally induced colitis by sup-pressing innate and adaptive immune responses[J]. J Neuroimmunol, 2015,289:43-55.
[8] Chitra P, Saiprasad G, Manikandan R , et al. Berberine attenuates bleomycin induced pulmonary toxicity and fibrosis via suppressing NF-κB dependant TGF- β activation: a biphasic experimental study[J]. Toxicol Lett, 2013,219(2):178-193.
[9] Zou K, Li Z, Zhang Y , et al. Advances in the study of berberine and its derivatives: a focus on antiinflam-matory and anti-tumor effects in the digestive system[J]. Acta Pharmacol Sin, 2017,38(2):157-167.
[10] Liu D, Meng X, Wu DL , et al. A natural isoquinoline alkaloid with antitumor activity: studies of the bio-logical activities of berberine[J]. Front Pharmacol, 2019,10:9.
[11] Mantena SK, Sharma SD, Katiyar SK . Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells[J]. Mol Cancer Ther, 2006,5(2):296-308.
[12] Yan KQ, Zhang C, Feng JB , et al. Induction of G1 cell cycle arrest and apoptosis by berberine in bladder cancer cells[J]. Eur J Pharmacol, 2011,661(1/ 2/3):1-7.
[13] James MA, Fu HJ, Liu Y , et al. Dietary administration of berberine or Phellodendron amurense extract inhibits cell cycle progression and lung tumorigenesis[J]. Mol Carcinog, 2011,50(1):1-7.
[14] Kim S, Han J, Lee SK , et al. Berberine suppresses the TPA-induced MMP-1 and MMP-9 expressions through the inhibition of PKC-α in breast cancer cells[J]. J Surg Res, 2012,176(1):e21-e29.
[15] Xu DH, Yang W, Zhou CH , et al. Preventive effects of berberine on glucocorticoid-induced osteoporosis in rats[J]. Planta Med, 2010,76(16):1809-1813.
[16] Hu JP, Nishishita K, Sakai E , et al. Berberine inhibits RANKL-induced osteoclast formation and survival through suppressing the NF-kappaB and Akt path-ways[J]. Eur J Pharmacol, 2008,580(1/2):70-79.
[17] Zhou XX, Zhang C, Wang XQ , et al. Berberine inhi-bits lipopolysaccharide- and polyethylene particle-induced mouse calvarial osteolysis in vivo[J]. J Surg Res, 2012,173(2):e47-e52.
[18] Lee HW, Suh JH, Kim HN , et al. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK[J]. J Bone Miner Res, 2008,23(8):1227-1237.
[19] Tao K, Xiao DM, Weng J , et al. Berberine promotes bone marrow-derived mesenchymal stem cells osteo-genic differentiation via canonical Wnt/β-catenin signaling pathway[J]. Toxicol Lett, 2016,240(1):68-80.
[20] Holick MF, Lamb JJ, Lerman RH , et al. Hop rho iso- alpha acids, berberine, vitamin D3 and vitamin K1 favorably impact biomarkers of bone turnover in postmenopausal women in a 14-week trial[J]. J Bone Miner Metab, 2010,28(3):342-350.
[21] Singh N, Sharma B . Toxicological effects of ber-berine and sanguinarine[J]. Front Mol Biosci, 2018,5:21.
[22] Marin-Neto JA, Maciel BC, Secches AL , et al. Cardiovascular effects of berberine in patients with severe congestive heart failure[J]. Clin Cardiol, 1988,11(4):253-260.
[23] Yin J, Xing HL, Ye JP . Efficacy of berberine in patients with type 2 diabetes mellitus[J]. Metab Clin Exp, 2008,57(5):712-717.
[24] Yao ZM, Zhang L, Ji G . Efficacy of polyphenolic ingredients of Chinese herbs in treating dyslipidemia of metabolic syndromes[J]. J Integr Med, 2014,12(3):135-146.
[25] Li M, Dang YQ, Li Q , et al. Berberine alleviates hyperglycemia by targeting hepatic glucokinase in diabetic db/db mice[J]. Sci Rep, 2019,9(1):8003.
[26] Kulkarni SK, Dhir A . On the mechanism of antide-pressant-like action of berberine chloride[J]. Eur J Pharmacol, 2008,589(1/2/3):163-172.
[27] Simões Pires EN, Frozza RL, Hoppe JB , et al. Ber-berine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved[J]. Brain Res, 2014,1557:26-33.
[28] 王少虎, 樊明文, 边专 . 中草药抗致龋菌的实验研究[J]. 中华口腔医学杂志, 2001,36(5):385-387.
Wang SH, Fan MW, Bian Z . Experimental study of bacteriostatic activity of Chinese herbal medicines on primary cariogenic bacteria in vitro[J]. Chin J Stomatol, 2001,36(5):385-387.
[29] Dziedzic A, Wojtyczka RD, Kubina R . Inhibition of oral streptococci growth induced by the complementary action of berberine chloride and antibacterial compounds[J]. Molecules, 2015,20(8):13705-13724.
[30] 苏瑞云, 任雷 . 黄连提取液对乳牙感染根管消毒作用的研究[J]. 中华口腔医学杂志, 1992,27(5):302-305, T017.
Su RY, Ren L . Study on the effect of Rhizoma Coptidis extract on root canal disinfection of deciduous teeth with infection[J]. Chin J Stomatol, 1992,27(5):302-305, T017.
[31] Xie Q, Johnson BR, Wenckus CS , et al. Efficacy of berberine, an antimicrobial plant alkaloid, as an endodontic irrigant against a mixed-culture biofilm in an in vitro tooth model[J]. J Endod, 2012,38(8):1114-1117.
[32] Kassebaum NJ, Bernabé E, Dahiya M , et al. Global burden of severe periodontitis in 1990-2010: a syste-matic review and Meta-regression[J]. J Dent Res, 2014,93(11):1045-1053.
[33] 吴益华, 姜广水, 张世周 , 等. 黄连水提取物药膜辅助治疗慢性牙周炎的疗效评价[J]. 上海口腔医学, 2004,13(4):252-255.
Wu YH, Jiang GS, Zhang SZ , et al. The clinical study on the adjunctive effects of aqueous extract from Coptis root for the treatment of chronic periodontitis[J]. Shanghai J Stomatol, 2004,13(4):252-255.
[34] Hu JP, Takahashi N, Yamada T . Coptidis rhizoma inhibits growth and proteases of oral bacteria[J]. Oral Dis, 2000,6(5):297-302.
[35] Jia X, Jia L, Mo L , et al. Berberine ameliorates per-iodontal bone loss by regulating gut microbiota[J]. J Dent Res, 2019,98(1):107-116.
[36] 孙俊毅, 朱春晖, 刘瑾 , 等. 盐酸小檗碱调节大鼠实验性牙周炎牙龈组织MMPs/TIMP 表达变化及其机制[J]. 西安交通大学学报(医学版), 2016,37(4):551-555.
Sun JY, Zhu CH, Liu J , et al. Berberine regulates MMPs/TIMP via inhibition of P38 MAPK/NF-κB phosphorylation and anti-inflammation in rat experi-mental periodontitis[J]. J Xi’an Jiaotong Univ (Med Sci), 2016,37(4):551-555.
[37] 张帆, 余占海 . 盐酸小檗碱对人牙周膜细胞分泌单核细胞趋化蛋白1影响的体外实验[J]. 中华口腔医学杂志, 2012,47(10):610-613.
Zhang F, Yu ZH . Effect of berberine hydrochloride on the secretion of monocyte chemoattractant protein-1 from human periodontal ligament cells in vitro[J]. Chin J Stomatol, 2012,47(10):610-613.
[38] 赵玮, 高承志 . 4种药物对大鼠牙周炎相关细胞因子影响的比较研究[J]. 实用口腔医学杂志, 2010,26(1):47-50.
Zhao W, Gao CZ . A comparative study of the effects of four kinds of drugs on periodontitis-related cyto-kines of rats[J]. J Pract Stomatol, 2010,26(1):47-50.
[39] Zhang R, Yang J, Wu J , et al. Berberine promotes osteogenic differentiation of mesenchymal stem cells with therapeutic potential in periodontal regeneration[J]. Eur J Pharmacol, 2019,851:144-150.
[40] Sun HL, Wu YR, Song FF , et al. Role of PCSK9 in the development of mouse periodontitis before and after treatment: a double-edged sword[J]. J Infect Dis, 2018,217(4):667-680.
[41] Sorsa T, Tjäderhane L, Konttinen YT , et al. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation[J]. Ann Med, 2006,38(5):306-321.
[42] Tu HP, Fu MM, Kuo PJ , et al. Berberine’s effect on periodontal tissue degradation by matrix metalloproteinases: an in vitro and in vivo experiment[J]. Phyto-medicine, 2013,20(13):1203-1210.
[43] Jiang XW, Zhang Y, Zhu YL , et al. Effects of ber-berine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2013,115(2):212-217.
[44] 万韬, 刘国素 . 盐酸小檗碱对口腔黏膜成纤维细胞分化的影响[J]. 细胞与分子免疫学杂志, 2011,27(4):440-441.
Wan T, Liu GS . Effect of berberine on the differentiation of oral fibroblasts[J]. Chin J Cell Mol Immunol, 2011,27(4):440-441.
[45] Kim JS, Oh D, Yim MJ , et al. Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells[J]. Oncol Rep, 2015,33(4):1775-1782.
[46] Ho YT, Yang JS, Li TC , et al. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-kappaB, U-PA and MMP-2 and-9[J]. Cancer Lett, 2009,279(2):155-162.
[1] Fu Yu, He Wei, Huang Lan. Ferroptosis and its implication in oral diseases [J]. Int J Stomatol, 2024, 51(1): 36-44.
[2] Luo Xiaojie,Wang Dexu,Chen Xiaotao. Relationship between periodontitis and ferroptosis based on bioinformatics analysis [J]. Int J Stomatol, 2023, 50(6): 661-668.
[3] Huang Yuanhong,Peng Xian,Zhou Xuedong.. Progress in research into the effect of Rhizoma Drynariae on the treatment of bone-related diseases in the oral cavity [J]. Int J Stomatol, 2023, 50(6): 679-685.
[4] Hu Jia,Wang Xiuqing,Lu Guoying,Huang Xiaojing.. Regenerative endodontic procedures for permanent tooth with immature apices in adult patients [J]. Int J Stomatol, 2023, 50(6): 686-695.
[5] Wu Jiamin,Xia Bin,Yang Hefeng,Xu Biao.. Research progress on cancer-associated fibroblasts in the tumor microenvironment of oral squamous cell carcinoma [J]. Int J Stomatol, 2023, 50(6): 711-717.
[6] Gong Meiling,Cheng Xingqun,Wu Hongkun.. Research progress on the correlation between Parkinson’s disease and periodontitis [J]. Int J Stomatol, 2023, 50(5): 587-593.
[7] Xu Zhibo,Meng Xiuping.. Research progress on mechanism of Enterococcus faecalis escaping host immune defense [J]. Int J Stomatol, 2023, 50(5): 613-617.
[8] Wang Gang,Chen Zhuo.. Reduction of the risk of caries after interproximal enamel reduction [J]. Int J Stomatol, 2023, 50(4): 395-400.
[9] Zhao Lingfan, Zhou Yang, Ye Xinxin, Zhang Qiang.. Poorly differentiated mucoepidermoid carcinoma of the parotid gland after renal transplantation: a case report [J]. Int J Stomatol, 2023, 50(4): 419-422.
[10] Zhang Chaoying,Li Yining,Gong Jiaxing,Wang Huiming. Interpretation of the 2022 classification of head and neck tumors by the World Health Organization: odontogenic and maxillofacial bone tumors [J]. Int J Stomatol, 2023, 50(3): 263-271.
[11] Sheng Nanning,Wang Jue,Nan Xinrong. Research progress on mechanism and treatment of sex-determining region Y box 9 in oral squamous cell carcinoma [J]. Int J Stomatol, 2023, 50(3): 314-320.
[12] Sun Jia,Han Ye,Hou Jianxia. Research progress on the role of interleukin-6-hepcidin signal axis in regulating the pathogenesis of periodontitis-associated anemia [J]. Int J Stomatol, 2023, 50(3): 329-334.
[13] Gao Ruofan,Xia Bin.. Severe early childhood caries management based on chronic disease management [J]. Int J Stomatol, 2023, 50(3): 341-346.
[14] Liang Zhiying,Zhao Yuanxi,Zhu Jiani,Su Qin.. Retrospective analysis of clinical data of 288 cases of endodontic microsurgery on anterior teeth [J]. Int J Stomatol, 2023, 50(2): 166-171.
[15] Li Tan,Liang Xin-hua.. Role of discoidin domain receptor 1 in the regulation of malignant tumor progression and therapy [J]. Int J Stomatol, 2023, 50(2): 230-236.
Full text



[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[7] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 458 -460 .
[8] . [J]. Foreign Med Sci: Stomatol, 2005, 32(06): 452 -454 .
[9] . [J]. Inter J Stomatol, 2008, 35(S1): .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .